ChemoCentryx (CCXI) PT Raised to $56 at Raymond James, 'Bull Case' $99
Tweet Send to a Friend
Raymond James analyst Steven Seedhouse raised the price target on ChemoCentryx (NASDAQ: CCXI) to $56.00 (from $17.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
